Sparrow Pharmaceuticals
sparrowpharma.comSparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess, associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as Prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.
Something looks off?Open jobs at Sparrow Pharmaceuticals
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.